Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
pharmacology, toxicology and pharmaceutics
SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: Development and optimization
International Journal of Pharmaceutics, Volume 391, No. 1-2, Year 2010
Notification
URL copied to clipboard!
Description
The aim of this study was to develop and optimize SNEDDS formulations containing surfactants reported to be bioenhancers for improvement of dissolution and oral absorption of lacidipine (LCDP). Preliminary screening was carried out to select proper components combination. D-optimal mixture experimental design was applied to optimize a SNEDDS that contains a minimum amount of surfactant, a maximum amount of lipid, and possesses enhanced emulsification and dissolution rates. Three formulation variables; the oil phase X1 (a mixture of Labrafil®/Capmul®), the surfactant X2 (a mixture of Cremophor®/Tween® 80) and the co-surfactant X3, were included in the design. The systems were assessed for droplet size, light absorbance, optical clarity, drug release and emulsification efficiency. Following optimization, the values of formulation components (X1, X2, and X3) were 34.20%, 40.41% and 25.39%, respectively. There is a good correlation between light absorbance and droplet size analysis of diluted SNEDDS (R2=0.883). Transmission electron microscopy demonstrated spherical droplet morphology. The stability of the optimized formulation was retained after storage at 40°C/75% RH for three months. The optimized formulation of LCDP showed a significant increase in dissolution rate compared to the drug suspension under the same conditions. Our results proposed that the optimized SNEDDS formulation, containing bioenhancing surfactants, could be promising to improve oral absorption of LCDP. © 2010 Elsevier B.V.
Authors & Co-Authors
Basalious, Emad B.
Egypt, Cairo
Faculty of Pharmacy
Abdelmalak, Nevine S.
Egypt, Cairo
Faculty of Pharmacy
Badr-Eldin, Shaimaa M.
Egypt, Cairo
Faculty of Pharmacy
Statistics
Citations: 272
Authors: 3
Affiliations: 1
Identifiers
Doi:
10.1016/j.ijpharm.2010.03.008
ISSN:
03785173
Research Areas
Health System And Policy